You’re on our free tier. Upgrade to NewsNow Essentials now and get your favourite news platform, faster, slicker and ads free.You’re on our free tier. Upgrade to NewsNow Essentials now. Faster, slicker and ads free.You’re on our free tier. Upgrade and go ads free now!

Home
Hot Topics
UK
World
Gaza
Ukraine
Iran
Climate Crisis
Business
Football
Sport
Entertainment
Tech
Science

AstraZeneca
Pharmaceuticals
GSK
Johnson and Johnson
AbbVie
Novartis
Novo Nordisk
Sanofi
Topics

Advertisement

AstraZeneca

Share

Top Latest Popular

NewsNow Essentials. Your favourite news platform, ads free. Upgrade now!

NewsNow Essentials. Your favourite news platform, ads free. Upgrade now!

In the last 10 minutes

FDA approves AstraZeneca’s Saphnelo for SLE Pharmaceutical Technology 09:27

AstraZeneca's asthma maintenance treatment receives US FDA approval ShareCast 09:23

Yesterday

UK–Shanghai partnership launches to accelerate life changing healthcare innovation University of Glasgow 16:58 Mon, 27 Apr

Advertisement

Advertisement

Citi sees Daiichi supply review as immaterial for AstraZeneca Proactive Investors (US) 13:24 Mon, 27 Apr

AstraZeneca signs 'landmark partnership' to transform healthcare in NI News Letter 11:40 Mon, 27 Apr

Saphnelo approved in the US for subcutaneous self‑administration PharmaTimes 10:26 Mon, 27 Apr

AstraZeneca's Saphnelo Pen gets green light from US FDA ShareCast 08:38 Mon, 27 Apr

Milestone Northern Irish healthcare and innovation partnership for AstraZeneca Insider Media 07:54 Mon, 27 Apr

Saphnelo approved in the US for subcutaneous self-administration as a new autoinjector for the treatment of systemic lupus erythematosus AstraZeneca (Press Release) 07:51 Mon, 27 Apr

Molten Ventures expects to report 'sharp rise' in both NAV and Gpv, AstraZeneca's Saphnelo receives US FDA approval ShareCast 07:43 Mon, 27 Apr

AstraZeneca: FDA Approves Saphnelo For Subcutaneous Self-administration RTT News 07:34 Mon, 27 Apr

Friday

Insights Into Astrazeneca (AZN) Q1: Wall Street Projections for Key Metrics Zacks 15:25 Fri, 24 Apr

Former AstraZeneca offices sold to Oeiras International School Portugal Resident 08:56 Fri, 24 Apr

GSK doubles down on oncology as AstraZeneca’s pipeline cranks up Investors Chronicle 08:32 Fri, 24 Apr

Astrazeneca (AZN) Suffers a Larger Drop Than the General Market: Key Insights Zacks 00:19 Fri, 24 Apr

Advertisement

Thursday

Global drug company AstraZeneca ‘hacked’ by teenage cyber gang Metro.co.uk 16:38 Thu, 23 Apr

AstraZeneca warns German reforms could push pharma launches and investment out of Europe EU Reporter 08:20 Thu, 23 Apr

Wednesday

AstraZeneca to seek accelerated approval of Ultomirisin in IgAN on Phase III data Clinical Trials Arena 14:50 Wed, 22 Apr

AstraZeneca launches Lokelma in Korea to prevent drop-off from key heart and kidney drugs Korea Biomedical Review 11:06 Wed, 22 Apr

In the last month

AstraZeneca's Ultomiris Meets Goal in Rare Kidney Disease Study Zacks 17:22 Tue, 21 Apr

AstraZeneca’s Ultomiris Hits Interim Phase III Endpoint In IgAN, Eyes Accelerated Filings Scrip Pharma Intelligence 15:53 Tue, 21 Apr

AstraZeneca eyes 5th Ultomiris indication after kidney disease trial win FiercePharma 15:52 Tue, 21 Apr

AstraZeneca's tozorakimab succeeds in third pivotal Phase III COPD trial Manufacturing Chemist 14:46 Tue, 21 Apr

AstraZeneca’s COPD drug gains third Phase III win Clinical Trials Arena 11:41 Tue, 21 Apr

AstraZeneca's tozorakimab treble puts $5bn sales ceiling in sight, says Citi Proactive Investors (US) 11:08 Tue, 21 Apr

AstraZeneca receives positive high level results from Phase III I can trial ShareCast 08:48 Tue, 21 Apr

AstraZeneca's Ultomiris hits primary endpoint in rare kidney disease trial Proactive Investors (UK) 08:19 Tue, 21 Apr

Widow welcomes Covid-19 vaccine compensation report BBC 18:21 Mon, 20 Apr

AZ is three for three with COPD hope tozorakimab pharmaphorum 12:03 Mon, 20 Apr

AstraZeneca secures green light for major Cambridge conference and office hub Building Design & Construction Magazine 10:43 Mon, 20 Apr

AstraZeneca reports positive top-line data from Phase III Miranda trial ShareCast 09:03 Mon, 20 Apr

AstraZeneca wins go-ahead for Cambridge conference centre Construction Enquirer 08:39 Mon, 20 Apr

Next phase of AstraZeneca campus development in Cambridge approved Building Magazine 12:34 Fri, 17 Apr

Jestico + Whiles’ AstraZeneca conference centre approved Building Design 17:00 Thu, 16 Apr

Executives On The Move: Ailux Gets A New CSO From AstraZeneca Scrip Pharma Intelligence 15:06 Thu, 16 Apr

Husband, 57, died 11 days after taking Oxford designed Covid jab Oxford Mail 13:52 Thu, 16 Apr

Astrazeneca (AZN) Stock Falls Amid Market Uptick: What Investors Need to Know Zacks 00:22 Thu, 16 Apr

AstraZeneca Korea seeks Truqap reimbursement as second-line gap persists in breast cancer Korea Biomedical Review 01:13 Wed, 15 Apr

Spanberger signs off on $191 million in grant funding for AstraZeneca plant WVIR 29 News 23:03 Tue, 14 Apr

Spanberger signs off on $191M grant for AstraZeneca's new plant outside Charlottesville Charlottesville Daily Progress, Virginia 11:21 Tue, 14 Apr

Advertisement

Advertisement

About our AstraZeneca news

Latest news on AstraZeneca, an Anglo-Swedish multinational pharmaceutical and biotechnology company based in Cambridge, with live updates on products and research.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Back to Industry Sectors Pharmaceuticals
- Abbott Laboratories
- AbbVie AbbVie
- AstraZeneca
- Baxter Baxter
- Bayer Bayer
- Boehringer Ingelheim
- Bristol Myers Squibb
- Eli Lilly Eli Lilly
- Genentech Genentech
- GlaxoSmithKline
- Johnson and Johnson
- Merck and Co
- Novartis Novartis
- Novavax Novavax
- Novo Nordisk
- Pfizer Pfizer
- Roche Roche
- Sanofi Sanofi
- Shire Shire
- Takeda Takeda
- Teva Teva
- Valneva Valneva
- Zoetis Zoetis